Skip to content

Alere Mycobacterium Tuberculosis Urine Study

Evaluation of Various Methods for the Detection of Mycobacterium Tuberculosis Nucleic Acid

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01585532
Enrollment
60
Registered
2012-04-26
Start date
2012-01-31
Completion date
2013-12-31
Last updated
2015-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Urine, Nucleic acid, Alere, Borstel

Brief summary

Current molecular methods will be evaluated for the detection of Mycobacterium tuberculosis specific nucleic acid in urine and blood of patients.

Interventions

None listed

Sponsors

Alere Technologies GmbH
CollaboratorINDUSTRY
Research Center Borstel
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected or confirmed tuberculosis * Age \>18 years * informed consent obtained

Exclusion criteria

* Previous participation in the study * Simultaneous participation in a clinical trial investigating a new drug * Inability to give consent * Member of a vulnerable study population

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificityOn admission to hospitalROC analysis to determine the best specificity and sensitivity to differentiate between patients with tuberculosis and patients with an alternative diagnosis

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026